Molecular Comparative Study of Virulence Factors Produced by Gram-Negative Bacteria Isolated from Several Cancer Cases and NonCancer Patients in Erbil Governorate, Iraq

IF 0.4 Q4 ENGINEERING, MULTIDISCIPLINARY
Saman I. Othman, Fattma A. Ali
{"title":"Molecular Comparative Study of Virulence Factors Produced by Gram-Negative Bacteria Isolated from Several Cancer Cases and NonCancer Patients in Erbil Governorate, Iraq","authors":"Saman I. Othman, Fattma A. Ali","doi":"10.25156/ptj.v12n2y2022.pp92-99","DOIUrl":null,"url":null,"abstract":"Background and objectives: Gram-negative bacteria are one of the most prevalent complications among immunocompromised cancer sufferers and pose the greatest threat to these patients.\nOur study aimed to conduct research on Gram-negative bacteria isolated from various clinical samples among cancerous patients and non-cancerous patients in Erbil city to analyze and compare some virulence genes among them such as tuf, atpD1, atpD2, ms-1, ms-2 and ms-3.\nMethods: The current study was carried out in Nanakaly hospital and other public health hospitals in Erbil- Kurdistan region at a period extending from August 2021 to March 2022.  A total of 100 different clinical samples including urine, sputum, wound swab, stool, blood, have been collected from patients with different types of cancer (n=50) and non-cancerous patients (n=50), from both gender (male and female), without limited age group. Gram-negative bacterial isolates identified by microscopical, macroscopical analysis and Vitek II compact system.\nResults: The results of amplification of tuf gene among the cancerous patients were (70%), while the results among the non-cancerous patients was (52%). The percentage of atpD1 from cancer patients were (52%), as well as the appearance among non-cancerous patients were (44%) isolates. The results of atpD2 among cancer patients were (52%). However, the average of atpD2 among patients without cancer were (48%). The results of agarose gel electrophoresis of amplicons appeared that (32%) samples possess ms-1 among cancer cases, while there have not any positive results for control patients. Also, the results of ms-2 gene were (28%) from cancer patients, whereas, the prevalence of ms-2 gene marker among patients without cancer was (6%). The distribution of ms-3 gene was (22%) among cancer patients. Otherwise, the prevalence from samples of patients other than cancer were (20%). According to the statistical tests, the results showed no significant association between genes and type of bacteria in cancerous patients as well as in non-cancerous patients.\nConclusions: tuf, atpD1 and atpD2 genes sealed a discriminated gene as a virulence factor encoding genes for identification of gram-negative bacteria. To the public health and especially from patients with cancer there is a main distribution of ms-1, ms-2 and ms-3 genes among gram-negative bacteria.","PeriodicalId":44937,"journal":{"name":"Journal of Polytechnic-Politeknik Dergisi","volume":"2 1","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Polytechnic-Politeknik Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25156/ptj.v12n2y2022.pp92-99","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Gram-negative bacteria are one of the most prevalent complications among immunocompromised cancer sufferers and pose the greatest threat to these patients. Our study aimed to conduct research on Gram-negative bacteria isolated from various clinical samples among cancerous patients and non-cancerous patients in Erbil city to analyze and compare some virulence genes among them such as tuf, atpD1, atpD2, ms-1, ms-2 and ms-3. Methods: The current study was carried out in Nanakaly hospital and other public health hospitals in Erbil- Kurdistan region at a period extending from August 2021 to March 2022.  A total of 100 different clinical samples including urine, sputum, wound swab, stool, blood, have been collected from patients with different types of cancer (n=50) and non-cancerous patients (n=50), from both gender (male and female), without limited age group. Gram-negative bacterial isolates identified by microscopical, macroscopical analysis and Vitek II compact system. Results: The results of amplification of tuf gene among the cancerous patients were (70%), while the results among the non-cancerous patients was (52%). The percentage of atpD1 from cancer patients were (52%), as well as the appearance among non-cancerous patients were (44%) isolates. The results of atpD2 among cancer patients were (52%). However, the average of atpD2 among patients without cancer were (48%). The results of agarose gel electrophoresis of amplicons appeared that (32%) samples possess ms-1 among cancer cases, while there have not any positive results for control patients. Also, the results of ms-2 gene were (28%) from cancer patients, whereas, the prevalence of ms-2 gene marker among patients without cancer was (6%). The distribution of ms-3 gene was (22%) among cancer patients. Otherwise, the prevalence from samples of patients other than cancer were (20%). According to the statistical tests, the results showed no significant association between genes and type of bacteria in cancerous patients as well as in non-cancerous patients. Conclusions: tuf, atpD1 and atpD2 genes sealed a discriminated gene as a virulence factor encoding genes for identification of gram-negative bacteria. To the public health and especially from patients with cancer there is a main distribution of ms-1, ms-2 and ms-3 genes among gram-negative bacteria.
伊拉克埃尔比勒省几例癌症患者与非癌症患者分离的革兰氏阴性菌产生毒力因子的分子比较研究
背景和目的:革兰氏阴性菌是免疫功能低下的癌症患者中最常见的并发症之一,对这些患者构成最大的威胁。我们的研究旨在对埃尔比勒市癌变患者和非癌变患者的各种临床样本中分离到的革兰氏阴性菌进行研究,分析比较其中的一些毒力基因,如tuf、atpD1、atpD2、ms-1、ms-2和ms-3。方法:本研究于2021年8月至2022年3月在埃尔比勒-库尔德斯坦地区的Nanakaly医院和其他公共卫生医院进行。收集了不同类型癌症患者(n=50)和非癌症患者(n=50)的尿液、痰、伤口拭子、粪便、血液等100种不同的临床样本,不分性别(男性和女性),没有年龄限制。通过显微、宏观分析和Vitek II紧凑系统鉴定革兰氏阴性细菌分离株。结果:肿瘤患者中tuf基因扩增率为(70%),非肿瘤患者中扩增率为(52%)。来自癌症患者的atpD1百分比为(52%),非癌症患者的外观为(44%)分离株。肿瘤患者的atpD2检测结果为(52%)。然而,无癌患者的平均atpD2为(48%)。琼脂糖凝胶电泳扩增子的结果显示,癌症患者中(32%)的样品含有ms-1,而对照组没有阳性结果。此外,ms-2基因在癌症患者中的检测结果为(28%),而ms-2基因标记在非癌症患者中的检测结果为(6%)。ms-3基因在肿瘤患者中的分布占22%。此外,非癌症患者样本的患病率为(20%)。根据统计检验,结果显示癌症患者和非癌症患者的基因和细菌类型之间没有显著的关联。结论:tuf、atpD1和atpD2基因封闭了一个鉴别基因作为鉴定革兰氏阴性菌的毒力因子编码基因。对公众健康,特别是对癌症患者而言,革兰氏阴性菌中主要分布着ms-1、ms-2和ms-3基因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Polytechnic-Politeknik Dergisi
Journal of Polytechnic-Politeknik Dergisi ENGINEERING, MULTIDISCIPLINARY-
自引率
33.30%
发文量
125
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信